Search
for

    Glossary Lenalidomide

    medication used to treat specific blood cancers by modulating immunity

    Lenalidomide is a medication primarily used to treat certain types of blood cancers, such as multiple myeloma and myelodysplastic syndromes. It works by modulating the immune system and inhibiting the growth of cancer cells. While it can be highly effective, it also has potential side effects, including an increased risk of blood clots and low blood cell counts.

    Sort by

    Research 30 of 87

    1. Hair repigmentation associated with the use of lenalidomide: Graying may not be an irreversible process! Journal of oncology pharmacy practice · 2012 · 25 citations
    2. Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects Cutaneous and Ocular Toxicology · 2013 · 18 citations
    3. Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus Lupus · 2016 · 14 citations
    4. Lenalidomide Augments Differentiation of Cultured Hair Follicle Derived Melanocyte Stem Cells Into Functional Melanocytes Dermatology practical & conceptual · 2023
    5. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist The Journal of Rheumatology · 2022 · 11 citations
    6. Cyclophosphamide-associated acneiform drug eruption in a patient with multiple myeloma Journal of the American Academy of Dermatology · 2011 · 5 citations
    7. Recent Insight on the Management of Lupus Erythematosus Alopecia Clinical, Cosmetic and Investigational Dermatology · 2021 · 3 citations
    8. Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review PloS one · 2024
    9. Cutaneous Lupus Erythematosus Springer eBooks · 2017
    10. Medication-Induced Repigmentation of Gray Hair: A Systematic Review Skin appendage disorders · 2019 · 28 citations
    11. Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis JAAD Case Reports · 2018 · 12 citations
    12. Premature graying of hair Indian Journal of Dermatology, Venereology and Leprology · 2013 · 47 citations
    13. TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia Cell Death and Disease · 2016 · 38 citations
    14. Androgen receptor modulators: a review of recent patents and reports (2012-2018) Expert Opinion on Therapeutic Patents · 2019 · 23 citations
    15. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus JAMA Dermatology · 2017 · 16 citations
    16. Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy Dermatology Review · 2016 · 4 citations
    17. Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease. BIOMED natural and applied science · 2025 · 3 citations
    18. Cutaneous drug reactions Elsevier eBooks · 2010 · 1 citations
    19. A Unique Acquired Athletic Dermatologic Condition in a Half Marathon Participant: An Autobiographical Case Report of Sports-Associated Clothing Related Axillary Tangled Clumped Hairs (SCRATCH) Cureus · 2025
    20. In vitro Differentiation of Melanocyte Stem Cells Derived from Vitiligo Patients into Functional Melanocytes The Indonesian Biomedical Journal · 2024
    21. Noval advance of histone modification in inflammatory skin diseases and related treatment methods Frontiers in immunology · 2024
    22. Hair greying & its palliative management Southeast Asian journal of health professionals · 2022
    23. Extensive scarring alopecia and widespread rash The Journal of Family Practice · 2022
    24. Poster Abstracts Fundamental & Clinical Pharmacology · 2017
    25. Table of Contents Journal of The American Academy of Dermatology · 2014
    26. Index 2013
    27. Discoid lupus erythematosus successfully treated with deucravacitinib JAAD Case Reports · 2024 · 13 citations
    28. Repigmentation of hair following adalimumab therapy Dermatology online journal · 2015 · 17 citations
    29. Alopecia secondary to severe discoid lupus responding to anifrolumab International Journal of Women’s Dermatology · 2023 · 5 citations
    30. Paraproteinemic keratopathy: recognizing the ocular significance Canadian Journal of Ophthalmology · 2022 · 1 citations